Patients with a specific type of heart failure were less active when taking a commonly prescribed nitrate medication thought to improve exercise capacity, according to a recent study co-authored by Northwestern Medicine investigator Sanjiv Shah, MD.
Children with allergic disease have about twice the rate of high blood pressure and high cholesterol, according to a new Northwestern Medicine study.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
Providing individualized feedback about the risk of developing cardiovascular disease to community health center patients increased treatment discussions with primary care physicians, according to a new Northwestern Medicine study.
A recent study co-authored by Northwestern Medicine scientists demonstrates the molecular mechanisms that may underlie left ventricular hypertrophy, a pattern of cardiac injury common in patients with chronic kidney disease.
Nina Gotteiner, MD, associate professor of Pediatrics in the Division of Cardiology, studied the outcomes and predictors of fetuses diagnosed with Epstein anomaly or tricuspid valve dysplasia.
Many patients on antihypertensive medications are at greater risk of cardiovascular disease, despite controlled numbers, according to a new Northwestern Medicine study.
Robert Bonow, MD, the Max and Lilly Goldberg Distinguished Professor of Cardiology, has been named editor-in-chief of JAMA Cardiology, a new journal in the JAMA Network that will debut in 2016.
In a recent study, Shuang Zhang, a fourth year student in the Driskill Graduate Program in the Life Sciences (DGP), shed light on a molecule that mediates cross-talk between cardiac cells and immune cells after injury.
